Age-related Macular Degeneration Market

Age-related Macular Degeneration Market Size, Share, Growth Analysis, By Product Outlook (Revenue, USD Million; Patient Share, 2018 - 2030)(Eylea, Lucentis, Beovu, Others), By Disease Type(Dry AMD, Wet AMD), By Distribution Channel(Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), By Regional(North America, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35I2072 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Age-related Macular Degeneration Market Insights

Market Overview:

The market for age-related macular degeneration was worth USD 9.84 billion in 2021, and from 2022 to 2030, it is anticipated to expand at a CAGR of 6.9%. The introduction of innovative treatments for age-related macular degeneration, an increase in the prevalence of AMD, and a robust product pipeline are what are driving the market. According to the World Health Organization (WHO), age-related macular degeneration will impact approximately 196 million people worldwide in 2020 and cause more than 10.4 million cases of moderate-to-severe vision impairment.

Age-related Macular Degeneration Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Age-related Macular Degeneration was estimated to be valued at US$ XX Mn in 2021.

The Age-related Macular Degeneration Market is estimated to grow at a CAGR of XX% by 2028.

The Age-related Macular Degeneration Market is segmented on the basis of Product Outlook (Revenue, USD Million; Patient Share, 2018 - 2030), Disease Type, Distribution Channel, Regional.

Based on region, the Age-related Macular Degeneration Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Age-related Macular Degeneration Market are F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Biogen, Samsung Bioepis.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Age-related Macular Degeneration Market

Report ID: UCMIG35I2072

$5,300
BUY NOW GET FREE SAMPLE